260 related articles for article (PubMed ID: 7904616)
1. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.
Kuechle MK; Stegemeir E; Maynard B; Gibson LE; Leiferman KM; Peters MS
J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):187-92. PubMed ID: 7904616
[TBL] [Abstract][Full Text] [Related]
2. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
[TBL] [Abstract][Full Text] [Related]
3. IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein.
Zone JJ; Taylor TB; Kadunce DP; Chorzelski TP; Schachner LA; Huff JC; Meyer LJ; Petersen MJ
J Invest Dermatol; 1996 Jun; 106(6):1277-80. PubMed ID: 8752670
[TBL] [Abstract][Full Text] [Related]
4. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
Billet SE; Kortuem KR; Gibson LE; El-Azhary R
Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
[TBL] [Abstract][Full Text] [Related]
5. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
[TBL] [Abstract][Full Text] [Related]
6. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature.
Plunkett RW; Chiarello SE; Beutner EH
J Am Acad Dermatol; 2001 Nov; 45(5):691-6. PubMed ID: 11606917
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.
Armstrong AW; Fazeli A; Yeh SW; Mackool BT; Liu V
J Cutan Pathol; 2004 May; 31(5):393-7. PubMed ID: 15059226
[TBL] [Abstract][Full Text] [Related]
8. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence.
Ohata C; Ishii N; Koga H; Nakama T
Br J Dermatol; 2017 Jul; 177(1):152-157. PubMed ID: 27943257
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin-associated linear IgA dermatosis. A report of three cases.
Carpenter S; Berg D; Sidhu-Malik N; Hall RP; Rico MJ
J Am Acad Dermatol; 1992 Jan; 26(1):45-8. PubMed ID: 1531056
[TBL] [Abstract][Full Text] [Related]
10. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience.
Arbache ST; Nogueira TG; Delgado L; Miyamoto D; Aoki V
An Bras Dermatol; 2014; 89(6):885-9. PubMed ID: 25387492
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced linear IgA bullous dermatosis probably induced by furosemide.
Cerottini JP; Ricci C; Guggisberg D; Panizzon RG
J Am Acad Dermatol; 1999 Jul; 41(1):103-5. PubMed ID: 10411419
[TBL] [Abstract][Full Text] [Related]
12. A successful challenge in a patient with vancomycin-induced linear IgA dermatosis.
Joshi S; Scott G; Looney RJ
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):101-3. PubMed ID: 15281479
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report.
Cummings JE; Snyder RR; Kelly EB; Raimer SS
Cutis; 2007 Mar; 79(3):203-7. PubMed ID: 17674585
[TBL] [Abstract][Full Text] [Related]
14. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
Watanabe M; Tsunoda T; Tagami H
Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
[TBL] [Abstract][Full Text] [Related]
15. Linear IgA bullous dermatosis associated with vancomycin and disseminated varicella-zoster infection.
Ahkami R; Thomas I
Cutis; 2001 May; 67(5):423-6. PubMed ID: 11381861
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
Baltazard T; Dhaille F; Duvert-Lehembre S; Lok C; Chaby G
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469749
[TBL] [Abstract][Full Text] [Related]
17. Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid.
Adachi A; Tani M; Matsubayashi S; Shibata K; Horikawa T; Murata Y; Kumano K
J Am Acad Dermatol; 1992 Sep; 27(3):394-9. PubMed ID: 1401273
[TBL] [Abstract][Full Text] [Related]
18. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
Waldman MA; Black DR; Callen JP
Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced linear IgA bullous dermatosis.
Onodera H; Mihm MC; Yoshida A; Akasaka T
J Dermatol; 2005 Sep; 32(9):759-64. PubMed ID: 16361722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
